Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past Paradoxes (Advances in Experimental Medicine and Biology, 773). Este artículo no está disponible.
Idioma: inglés
Editorial: Springer, 2016
Serie: Libro 160 de 544 - Advances in Experimental Medicine and Biology
- Tapa blanda
- Nuevo

Librería: Books Puddle, Woodside, NY, Estados Unidos de AmericaBooks Puddle
Vendedor de IberLibro desde 22 de noviembre de 2018
Condición: Nuevo
EUR 482,75
Descripción del artículo del vendedor
pp. 611.
N° de ref. del artículo 26375026915
- Título
- Cancer Biology and the Nuclear Envelope: Recent Advances May Elucidate Past Paradoxes (Advances in Experimental Medicine and Biology, 773)
- Editorial
- Springer
- Año de publicación
- 2016
- Estado
- New
- Encuadernación
- Encuadernación de tapa blanda
- Idioma
- inglés
- ISBN 10
- 1493954814
- ISBN 13
- 9781493954810
- Serie
- Libro 160 de 544: Advances in Experimental Medicine and Biology
"Nuclear envelope (NE) defects have been linked to cancer biology since the mid-1800s, but it was not until the last few years that we have begun to understand these historical links and to realize that there are myriad ways that the NE impacts on tumorigenesis. The NE is a complex double membrane system that encloses the genome while providing structural support through the intermediate filament lamin polymer and regulating protein/ mRNA trafficking and signaling between the nucleus and cytoplasm via the nuclear pore complexes (NPCs). These functions already provide some mechanisms for NE influences on cancer biology but work in the past few years has elucidated many others. Lamins and many recently identified NE transmembrane proteins (NETs) have been now shown to function in DNA repair, regulation of cell cycle and signaling, apoptosis, cell migration in metastasis and nuclear architecture and morphology. This volume presents a comprehensive overview of the wide range of functions recently identified for NE proteins and their relevance in cancer biology, providing molecular mechanisms and evidence of their value as prognostic and diagnostic markers and suggesting new avenues for the treatment of cancer. Indeed some of these recent links are already yielding promising therapies, such as the current clinical trial of selective inhibitors of the nuclear export factor exportin in certain types of leukemia, melanoma and kidney cancer."
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
“Acerca de” puede pertenecer a otra edición de este título.